Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Nasrazadani, Azadeh
44  Ergebnisse:
Personensuche X
?
1

Triple-Negative Breast Cancer and Emerging Therapeutic Stra..:

Sofianidi, Amalia ; Dumbrava, Ecaterina E. ; Syrigos, Konstantinos N..
Cancers.  16 (2024)  6 - p. 1139 , 2024
Link: https://doi.org/10.3390/..
 
?
2

Poziotinib treatment in patients with HER2-positive advance..:

Nasrazadani, Azadeh ; Marti, Juan Luis Gomez ; Lathrop, Kate...
Breast Cancer Research and Treatment.  205 (2024)  1 - p. 29-37 , 2024
Link: https://doi.org/10.1007/..
 
?
3

Twenty-Year Follow-Up of a Phase II Trial of Taxotere/Carbo..:

Gomez Marti, Juan Luis ; Nasrazadani, Azadeh ; Ding, Ying..
The Oncologist.  28 (2023)  11 - p. e1123-e1126 , 2023
Link: https://doi.org/10.1093/..
 
?
4

Mixed invasive ductal lobular carcinoma is clinically and p..:

Nasrazadani, Azadeh ; Li, Yujia ; Fang, Yusi...
British Journal of Cancer.  128 (2023)  6 - p. 1030-1039 , 2023
Link: https://doi.org/10.1038/..
 
?
5

Invasive Carcinoma With Skin Adnexal Trichilemmal Hair Foll..:

Olayinka, Oluwaseyi ; Cox, Solange E. ; Nasrazadani, Azadeh...
International Journal of Surgical Pathology.  32 (2023)  4 - p. 796-802 , 2023
Link: https://doi.org/10.1177/..
 
?
6

Absence of lobular carcinoma in situ is a poor prognostic m..:

Mouabbi, Jason A. ; Raghavendra, Akshara Singareeka ; Bassett Jr., Roland L....
European Journal of Cancer.  191 (2023)  - p. 113250 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Clinicopathological Features and Outcomes Comparing Patient..:

Oesterreich, Steffi ; Nasrazadani, Azadeh ; Zou, Jian...
JNCI: Journal of the National Cancer Institute.  114 (2022)  11 - p. 1511-1522 , 2022
Link: https://doi.org/10.1093/..
 
?
8

Personalising therapy for early-stage oestrogen receptor-po..:

Carleton, Neil ; Nasrazadani, Azadeh ; Gade, Kristine...
The Lancet Healthy Longevity.  3 (2022)  1 - p. e54-e66 , 2022
Link: https://doi.org/10.1016/..
 
?
9

Breast cancer mortality as a function of age:

Nasrazadani, Azadeh ; Marti, Juan Luis Gomez ; Kip, Kevin E....
Aging.  14 (2022)  3 - p. 1186-1199 , 2022
Link: https://doi.org/10.18632..
 
?
10

Doxorubicin induced tongue hyperpigmentation:

Rupert, Karlyn L. ; Ahmad, Rabiah ; Brufsky, Adam M..
Current Problems in Cancer: Case Reports.  5 (2022)  - p. 100147 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Ongoing Clinical Studies and Future Directions:

, In: Management of the Breast and Axilla in the Neoadjuvant Setting,
Nasrazadani, Azadeh ; Marti, Juan Luis Gomez ; Hyder, Tara.. - p. 351-370 , 2021
Link: https://doi.org/10.1007/..
 
?
12

Ovarian function suppression as a potential mechanism of ch..:

Gomez Marti, Juan Luis ; Nasrazadani, Azadeh ; Brufsky, Adam M.
EBioMedicine.  70 (2021)  - p. 103489 , 2021
Link: https://doi.org/10.1016/..
 
?
13

Aromatase Inhibitor-Associated Musculoskeletal Syndrome: Un..:

Hyder, Tara ; Marino, Christopher C. ; Ahmad, Sasha..
Frontiers in Endocrinology.  12 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
14

Approaching Neoadjuvant Therapy in the Management of Early-..:

Hyder, Tara ; Bhattacharya, Saveri ; Gade, Kristine..
Breast Cancer: Targets and Therapy.  13 (2021)  - p. 199-211 , 2021
Link: https://doi.org/10.2147/..
 
?
15

The Evolving Landscape of HER2-Directed Breast Cancer Thera..:

Marti, Juan Luis Gomez ; Hyder, Tara ; Nasrazadani, Azadeh.
Current Treatment Options in Oncology.  21 (2020)  10 - p. , 2020
Link: https://doi.org/10.1007/..
 
1-15